This inventor holds 23 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: Yeda Research and Develpment & Co. Ltd, Modus Biological Membranes Ltd., Ben-Gurion University of the Negev Research and Development Authority. Active years: 1976-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shmariyahu, IL (2000)
- Kfar Shmariyahu, IL (2001 - 2002)
- Rehovoth, IL (1976 - 2005)
- Kfar Shmaryahu, IL (1997 - 2015)
- Rehovot, IL (1978 - 2022)
Company Filing History:
17 out of 1,168 
3 out of 3 
1 out of 364 
Years Active: 1976-2022
Areas of Expertise:
Title: Innovations and Contributions of Meir Shinitzky
Introduction: Meir Shinitzky, based in Kfar Shmaryahu, Israel, is a prolific inventor with an impressive portfolio consisting of 23 patents. His groundbreaking work primarily focuses on the fields of biochemistry and immunology, contributing significantly to the advancement of scientific understanding and medical applications.
Latest Patents: Among his latest inventions, two notable patents stand out. The first is titled "Peptide combinations for use in the diagnosis of schizophrenia." This patent presents a composition that includes combinations of at least one short peptide and a peptide dimer, designed to bind with autoantibodies found in higher levels in patients with schizophrenia. The second patent involves "Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents." This innovative formulation provides a method for utilizing basic esters of fatty alcohols to treat immunologically-mediated inflammation and enhance antigen responses.
Career Highlights: Throughout his career, Meir Shinitzky has been involved with significant research institutions, notably Yeda Research and Development Company Ltd. and Modus Biological Membranes Ltd. His work in these organizations has facilitated various advancements in biotechnology and therapeutic methods, reflecting his dedication to improving health outcomes through innovative solutions.
Collaborations: Meir has collaborated with prominent figures in the field, including Irun R Cohen and Avner Shenfeld. These partnerships emphasize the importance of collaboration in scientific research and the sharing of knowledge that drives innovation.
Conclusion: Meir Shinitzky's contributions to the fields of biochemistry and immunology demonstrate a remarkable blend of creativity and scientific expertise. His 23 patents highlight a commitment to addressing complex medical challenges through innovative solutions. As he continues to push the boundaries of research, the potential impact of his work offers hope for advancements in diagnostic and therapeutic practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile